Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of

Blood Research and DisordersISSN: 2469-5696

Early Online

 Open Access DOI:10.23937/2469-5696/1410101

Intraoperative Bleeding During Mammoplasty and Dermolipectomy: A Case of Glanzmann's Thrombasthenia

Lucas Gabriel Muller, Samantha Cristiane Lopes, Angelo de Faveri, Gustavo Barbosa David and Taruana Schutz

Article Type: Case Report | Indexed Archive: Volume 12

The study presents an epidemiological design of the descriptive observational type, involving analysis of the patient's medical records. Approval was obtained from the Human Research Ethics Committee. The case description adhered to the precepts outlined in the CARE Guideline....

 Open Access DOI:10.23937/2469-5696/1410100

Is Clomiphene the Culprit?

Sristee Niraula, Shital Oli, Nishant Sharma Banjara, Srijana Niraula and Resha Khanal

Article Type: Case Report | Indexed Archive: Volume 12

Pulmonary embolism is a well known culprit in the medical world with a mortality as high as 30% for untreated population. Multiple risk factors have been described including, but not limited to immobility, trauma, oral contraceptive use, drugs, and malignancy. One of the most common risk factors widely recognized is oral contraceptive use in females....

 Open Access DOI:10.23937/2469-5696/1410099

K₂EDTA vs K₃EDTA Stability in Yemen: Sysmex KX-21N Performance in Tropical Lab

Naif Taleb Ali

Article Type: Case Report | Indexed Archive: Volume 12

Haematological diagnostics occupy a central role in clinical decision-making, with the complete blood count (CBC) serving as a fundamental test for conditions ranging from anaemia to infection. However, the accuracy of CBC results is profoundly influenced by preanalytical variables, particularly the choice of anticoagulant and sample processing timelines (Lippi, 2017)....

 Open Access DOI:10.23937/2469-5696/1410098

Evaluation of Changes in Levels of P-Selectin, C-Reactive Protein and Hematological Indices in CPD - A Blood Stored for 35 Days in Port Harcourt before Transfusion

Mercy Dein George, Stella U. Ken-Ezihuo and Evelyn M. Eze

Article Type: Original Research | Indexed Archive: Volume 12

Long-term storage of whole blood results in lesions, alterations in the biophysical, biochemical, and immunological characteristics of the cells. Each year, in Nigeria, about 1.5 million units of blood are used for blood transfusions as treatment intervention to a variety of medical conditions. This cross-sectional study evaluated changes in the levels of P-selectin, C-reactive protein and Hematological indices with respect to long-time storage of whole blood meant for transfusion in Port Harcou...

 Open Access DOI:10.23937/2469-5696/1410097

Impact of Education Program about Knowledge and Practice of Thalassemic Adolescent in Rahma Governmental Hospital, Jordan, Irbid

Laith Alosoufe

Article Type: Research Article | Indexed Archive: Volume 11

Teenagers with thalassemia require knowledge about their condition in order to give adequate care, eliminate uncertainty, and create reasonable goals for themselves. The aim of the present study was to assess the knowledge and practices among adolescents with thalassemia at Rahma Governmental Hospital, Jordan, Irbid....

 Open Access DOI:10.23937/2469-5696/1410096

The Association between Iron Deficiency Anaemia and Leukopenia, and the Effect of Intravenous Iron Correction on Leukopenia

Joanna Kae Ling Wong, Charlotte Chu-Hong Zheng, Samuel McGowan-Smyth and Chiraag Talati

Article Type: Original Article | Indexed Archive: Volume 11

Iron deficiency anaemia (IDA) has been observed concomitantly with unexplained leukopenia. However, this association is limited in literature. We investigated the association between IDA and leukopenia and explored iron therapy as a novel approach to improving immune function in patients with leukopenia....

 Open Access DOI:10.23937/2469-5696/1410095

Complications and Response to Treatment Regimens among Multiple Myeloma Patients Attended at Muhimbili National Hospital

Dorothy P Kasubi, Clara C Chamba, Neema Budodi and Samira Mahfudh

Article Type: Original Article | Indexed Archive: Volume 11

Multiple myeloma is a potentially fatal hematological malignancy characterized by clonal growth of terminally differentiated B cells. The development of novel medicines (proteasome inhibitors, immunomodulatory medications, antibodies targeting cell surface molecules, and autologous stem cell transplantation) has improved patients' quality of life and overall survival rate with multiple myeloma. Despite the advancement of these new therapies that help resolve disease progression and hence provide...

Volume 11
Issue 1